Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation
- PMID: 11557669
- DOI: 10.1161/hq0901.097004
Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation
Abstract
To investigate a potential role for stromelysin-1 (MMP-3) in the development and progression of atherosclerotic lesions and aneurysm formation, mice with a deficiency of apolipoprotein E (ApoE(-/-):MMP-3(+/+))) or with a combined deficiency of apoE and MMP-3 (ApoE(-/-):MMP-3(-/-)) were kept on a cholesterol-rich diet for 30 weeks. Atherosclerotic lesions throughout the thoracic aorta were significantly larger in ApoE(-/-):MMP-3(-/-) than in ApoE(-/-):MMP-3(+/+) mice (P<0.05) and contained more fibrillar collagen (P<0.01). Aneurysms in the thoracic and abdominal aortas were less frequent in ApoE(-/-):MMP-3(-/-) than in ApoE(-/-):MMP-3(+/+) mice (8.5+/-1.7% vs 14+/-2.1% of sections, mean+/-SD, P<0.01). Immunocytochemistry revealed enhanced accumulation of macrophages in atherosclerotic lesions of ApoE(-/-):MMP-3(+/+) mice (P<0.01) and expression of urokinase-type plasminogen activator (u-PA) and MMP-3 colocalizing with macrophages. Zymography confirmed the presence of u-PA and MMP-3 activity in extracts of atherosclerotic aortas. These data suggest that plasmin, generated by macrophage-secreted u-PA, activates pro-MMP-3 produced by accumulated macrophages. MMP-3 activity may then contribute to a reduction of plaque size, possibly by degradation of matrix components, and promote aneurysm formation by degradation of the elastica lamina.
Comment in
-
Contrasting outcomes of atheroma evolution: intimal accumulation versus medial destruction.Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1389-92. Arterioscler Thromb Vasc Biol. 2001. PMID: 11557661 No abstract available.
Similar articles
-
Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) gene.Circ Res. 2002 May 3;90(8):897-903. doi: 10.1161/01.res.0000016501.56641.83. Circ Res. 2002. PMID: 11988491
-
Extracellular proteolysis in the development and progression of atherosclerosis.Biochem Soc Trans. 2002 Apr;30(2):163-7. Biochem Soc Trans. 2002. PMID: 12023844 Review.
-
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.Nat Genet. 1997 Dec;17(4):439-44. doi: 10.1038/ng1297-439. Nat Genet. 1997. PMID: 9398846
-
Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.Circulation. 2004 Mar 23;109(11):1408-14. doi: 10.1161/01.CIR.0000121728.14930.DE. Epub 2004 Mar 1. Circulation. 2004. PMID: 14993123
-
Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development.J Vasc Res. 2006;43(6):493-501. doi: 10.1159/000095309. Epub 2006 Aug 24. J Vasc Res. 2006. PMID: 16931892
Cited by
-
The anti-inflammatory effects of exercise training promote atherosclerotic plaque stabilization in apolipoprotein E knockout mice with diabetic atherosclerosis.Eur J Histochem. 2013 Mar 25;57(1):e3. doi: 10.4081/ejh.2013.e3. Eur J Histochem. 2013. PMID: 23549462 Free PMC article.
-
The role of matrix metalloproteinases in atherothrombosis.Curr Atheroscler Rep. 2011 Apr;13(2):162-9. doi: 10.1007/s11883-010-0159-7. Curr Atheroscler Rep. 2011. PMID: 21271310 Review.
-
Ascending thoracic aortic aneurysms protect against myocardial infarctions.Int J Angiol. 2014 Sep;23(3):177-82. doi: 10.1055/s-0034-1382288. Int J Angiol. 2014. PMID: 25317029 Free PMC article.
-
Ascending Aortic Proaneurysmal Genetic Mutations with Antiatherogenic Effects.Int J Angiol. 2015 Sep;24(3):189-97. doi: 10.1055/s-0035-1556075. Epub 2015 Aug 17. Int J Angiol. 2015. PMID: 26417187 Free PMC article.
-
Febuxostat, a Xanthine Oxidase Inhibitor, Decreased Macrophage Matrix Metalloproteinase Expression in Hypoxia.Biomedicines. 2020 Nov 3;8(11):470. doi: 10.3390/biomedicines8110470. Biomedicines. 2020. PMID: 33153000 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous